Skip to content
Research Article Open access CC BY 4.0

Artificial Intelligence-Based Alzheimer’s Disease Classification Using Brain MRI: A Review of Machine Learning, Deep Learning and Emerging Intelligent Approaches

S. Deepa, A. Davincy Merline Sharmya, M. Gnanaprakash, D. Periyaazhagar

Journal of Engineering Research and Reports · pp. 67–79 · Published 11 Sep 2026

10.9734/jerr/2026/v28i91998

Abstract

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that affects memory, reasoning, language, and other cognitive functions. Early identification is important because structural brain changes may occur before severe clinical symptoms become evident. Magnetic Resonance Imaging (MRI) provides detailed anatomical information and has therefore become an important source for computer-aided Alzheimer’s disease assessment. Artificial intelligence (AI) techniques have increasingly been applied to MRI-based classification, progressing from handcrafted features and conventional machine-learning methods to deep-learning approaches. Traditional methods use morphological, textural, statistical, and frequency-domain features with classifiers such as Support Vector Machine, Random Forest, and Artificial Neural Networks. Deep-learning models, including Convolutional Neural Networks (CNNs), three-dimensional CNNs, transfer-learning architectures, ResNet, DenseNet, and EfficientNet, can automatically learn disease-related image representations. Recent approaches, including Vision Transformers, Explainable Artificial Intelligence (XAI), multimodal learning, federated learning, and self-supervised learning, aim to improve global feature representation, interpretability, data utilisation, privacy, and generalisation. This review examines the development of AI techniques for MRI-based Alzheimer’s disease classification, including datasets, preprocessing, feature extraction, deep learning, and emerging methods. A comparative discussion highlights their strengths and limitations, while major challenges such as limited datasets, class imbalance, scanner variability, computational complexity, and insufficient external validation are discussed. Future research should focus on robust, explainable, multimodal, privacy-aware, and clinically validated AI systems.

Alzheimer’s disease brain MRI machine learning deep learning convolutional neural network 3D CNN transfer learning vision transformer explainable artificial intelligence multimodal learning

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.